Casual beginnings for an innovative collaboration.

Jun 15, 2015 | News, Research & Innovation

Great coverage of TargetCancer Foundation’s support of an innovative esophageal cancer collaboration at the Dana-Farber Cancer Institute.

What started as a casual conversation over coffee has led to unexpected discoveries that are paving the way for effective use of immunotherapies to treat esophageal cancer.

Read the entire article here.

This article first appeared in Dana-Farber Cancer Institute’s Inside the Institute and is reprinted with permission.

You can also learn more about TargetCancer Foundation’s ongoing esophageal cancer research funding here.